Income Statement Pluri Inc.

Stocks

PLUR

US72942G2030

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-10 EDT			5-day change	1st Jan Change
1.250 ^USD	-8.76%		-8.76%	-58.19%

09-10	Pluri Inc. Reports Earnings Results for the Full Year Ended June 30, 2026	CI
07-28	Cellav Health and Aesthetics Ltd Completes Regulatory Registration of Regenativo+ in the UK	CI

d.INnDrrufGhW3y-A9VBP58AkDc9kxWro03j43zMwEirY.de-X74LxKE3ak4dEGH2SgSRENolCFeIN7l0Gj5RFstJVk63CjtRRU-Oy1A

Published financial data: PLURI INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Revenues	234K	287K	326K	1.34M	1.02M
Total Revenues	234K	287K	326K	1.34M	1.02M
Cost of Goods Sold, Total	-	9K	4K	682K	563K
Gross Profit	234K	278K	322K	654K	453K
Selling General & Admin Expenses, Total	18.65M	11.78M	10.03M	9.98M	10.3M
R&D Expenses	23.18M	15.74M	12.45M	12.85M	15.09M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	41.83M	27.52M	22.48M	22.83M	25.39M
Operating Income	-41.59M	-27.25M	-22.16M	-22.18M	-24.94M
Interest Expense, Total	-887K	-843K	-866K	-873K	-932K
Interest And Investment Income	581K	1.08M	1.31M	1.14M	-
Net Interest Expenses	-306K	241K	448K	271K	-932K
Currency Exchange Gains (Loss)	550K	-1.87M	126K	-2.16M	-
Other Non Operating Income (Expenses)	-25K	-16K	240K	807K	476K
EBT, Excl. Unusual Items	-41.37M	-28.89M	-21.34M	-23.26M	-25.39M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
EBT, Incl. Unusual Items	-41.37M	-28.89M	-21.34M	-23.26M	-25.39M
Income Tax Expense	-	-	-	-5K	-25K
Earnings From Continuing Operations	-41.37M	-28.89M	-21.34M	-23.25M	-25.37M
Net Income to Company	-41.37M	-28.89M	-21.34M	-23.25M	-25.37M
Minority Interest	132K	566K	456K	667K	1.55M
Net Income - (IS)	-41.24M	-28.32M	-20.89M	-22.58M	-23.82M
Net Income to Common Incl Extra Items	-41.24M	-28.32M	-20.89M	-22.58M	-23.82M
Net Income to Common Excl. Extra Items	-41.24M	-28.32M	-20.89M	-22.58M	-23.82M
Per Share Items
Net EPS - Basic	-10.25	-6.18	-3.99	-3.56	-2.44
Basic EPS - Continuing Operations	-10.25	-6.18	-3.99	-3.56	-2.44
Basic Weighted Average Shares Outstanding	4.02M	4.58M	5.24M	6.34M	9.74M
Net EPS - Diluted	-10.25	-6.18	-3.99	-3.56	-2.44
Diluted EPS - Continuing Operations	-10.25	-6.18	-3.99	-3.56	-2.44
Diluted Weighted Average Shares Outstanding	4.02M	4.58M	5.24M	6.34M	9.74M
Normalized Basic EPS	-6.39	-3.82	-2.46	-2.19	-1.47
Normalized Diluted EPS	-6.39	-3.82	-2.46	-2.19	-1.47
Supplemental Items
EBITDA	-40.54M	-26.88M	-21.9M	-21.86M	-24.43M
EBITA	-41.59M	-27.25M	-22.16M	-22.18M	-24.94M
EBIT	-41.59M	-27.25M	-22.16M	-22.18M	-24.94M
EBITDAR	-39.35M	-26.92M	-21.96M	-21.89M	-
Effective Tax Rate - (Ratio)	-	-	-	0.02	0.1
Normalized Net Income	-25.73M	-17.49M	-12.88M	-13.87M	-14.32M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	835K	732K	632K	663K	-
Supplemental Operating Expense Items
General and Administrative Expenses	17.45M	11.78M	10.03M	9.98M	10.3M
Research And Development Expense From Footnotes	24.6M	17.41M	13.78M	14M	15.09M
Net Rental Expense, Total	1.19M	-36K	-50K	-30K	-
Imputed Operating Lease Interest Expense	316K	-8.27K	-11.64K	-6.58K	-
Imputed Operating Lease Depreciation	871K	-27.73K	-38.36K	-23.42K	-
Stock-Based Comp., R&D Exp. (Total)	592K	56K	316K	463K	-
Stock-Based Comp., G&A Exp. (Total)	8.32M	2.93M	1.66M	1.52M	-
Stock-Based Comp., Other (Total)	-	-	645K	161K	-
Total Stock-Based Compensation	8.91M	2.98M	2.62M	2.14M	-

Fiscal Period: June	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Assets
Cash And Equivalents	9.77M	5.36M	6.78M	5.9M	3.53M
Short Term Investments	45.24M	34.81M	23.2M	14.72M	4.28M
Total Cash And Short Term Investments	55.02M	40.17M	29.98M	20.61M	7.8M
Accounts Receivable, Total	-	-	244K	320K	87K
Other Receivables	1.32M	417K	402K	402K	-
Total Receivables	1.32M	417K	646K	722K	87K
Prepaid Expenses	403K	442K	222K	235K	810K
Restricted Cash	1.01M	269K	254K	422K	29K
Other Current Assets, Total	-	110K	-	103K	-
Total Current Assets	57.75M	41.41M	31.11M	22.1M	8.73M
Gross Property Plant And Equipment	26.09M	25.77M	24.95M	26.71M	-
Accumulated Depreciation	-17.08M	-17.45M	-17.7M	-17.99M	-
Net Property Plant And Equipment	9.01M	8.32M	7.25M	8.72M	7.73M
Goodwill	-	-	-	3.14M	3.14M
Other Intangibles, Total	-	-	-	2.79M	2.61M
Other Long-Term Assets, Total	1.31M	1.07M	1.17M	1.94M	2.67M
Total Assets	68.06M	50.8M	39.53M	38.68M	24.88M
Liabilities
Accounts Payable, Total	1.78M	1.81M	964K	866K	702K
Accrued Expenses, Total	3.86M	3.04M	2.81M	3.16M	1.84M
Short-term Borrowings	-	-	-	-	27.43M
Current Portion of Long-Term Debt	-	-	-	27.29M	-
Current Portion of Leases	619K	627K	559K	659K	996K
Unearned Revenue Current, Total	112K	144K	81K	193K	-
Other Current Liabilities	457K	-	43K	162K	1.75M
Total Current Liabilities	6.83M	5.62M	4.45M	32.33M	32.72M
Long-Term Debt	21.68M	23.53M	24.03M	-	-
Long-Term Leases	6.5M	5.75M	5.03M	6.1M	6.49M
Deferred Tax Liability Non Current	-	-	-	415K	384K
Other Non Current Liabilities	867K	598K	605K	703K	2.72M
Total Liabilities	35.88M	35.5M	34.11M	39.55M	42.31M
Common Stock, Total	-	-	-	-	-
Additional Paid In Capital	401M	413M	421M	436M	444M
Retained Earnings	-371M	-400M	-420M	-443M	-467M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	30.04M	13.36M	96K	-6.84M	-23.04M
Minority Interest	2.15M	1.94M	5.32M	5.98M	5.6M
Total Equity	32.19M	15.3M	5.42M	-865K	-17.43M
Total Liabilities And Equity	68.06M	50.8M	39.53M	38.68M	24.88M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.08M	5.17M	5.47M	8.16M	10.68M
ECS Total Common Shares Outstanding	4.06M	5.16M	5.41M	7.89M	10.68M
Book Value / Share	7.39	2.59	0.02	-0.87	-2.16
Tangible Book Value	30.04M	13.36M	96K	-12.77M	-28.78M
Tangible Book Value Per Share	7.39	2.59	0.02	-1.62	-2.7
Total Debt	28.8M	29.9M	29.61M	34.05M	34.91M
Net Debt	-26.21M	-10.27M	-373K	13.44M	27.11M
Debt Equivalent of Unfunded Proj. Benefit Obligation	206K	159K	135K	93K	-
Debt Equivalent Oper. Leases	9.5M	-288K	-400K	-240K	-
Minority Interest, Total (Incl. Fin. Div)	2.15M	1.94M	5.32M	5.98M	5.6M
Account Code - Inventory Valuation	3	3	3	3	-
Machinery, Total	9.08M	9.37M	9.62M	10.64M	-
Full Time Employees	154	123	106	127	-
Part Time Employees	5	11	12	15	-

Fiscal Period: June	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Net Income	-41.24M	-28.32M	-20.89M	-22.58M	-23.82M
Depreciation & Amortization - CF	1.05M	362K	253K	316K	511K
Depreciation & Amortization, Total	1.05M	362K	253K	316K	511K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	8.91M	3.98M	2.62M	2.14M	3.73M
Other Operating Activities, Total	3.08M	265K	-203K	-2.28M	-1.58M
Change In Accounts Receivable	-	-	-	-202K	149K
Change In Accounts Payable	-758K	-22K	-778K	-235K	-77K
Change in Other Net Operating Assets	-7.54M	882K	977K	4.63M	1.51M
Cash from Operations	-36.5M	-22.86M	-18.02M	-18.21M	-19.59M
Capital Expenditure	-280K	-262K	-323K	-1.62M	-633K
Sale of Property, Plant, and Equipment	-	-	-	-	18K
Investment in Marketable and Equity Securities, Total	12.06M	9.96M	10.91M	9.27M	10.52M
Other Investing Activities, Total	-	-	-	373K	-
Cash from Investing	11.78M	9.7M	10.58M	8.03M	9.9M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Issuance of Common Stock	-	8.47M	253K	10M	6.32M
Other Financing Activities, Total	7.5M	-445K	8.59M	-467K	714K
Cash from Financing	7.5M	8.02M	8.84M	9.53M	7.04M
Foreign Exchange Rate Adjustments	-3.21M	-22K	11K	177K	27K
Net Change in Cash	-20.42M	-5.16M	1.42M	-475K	-2.62M
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-21.85M	-14.19M	-12.82M	-13.44M	-15.82M
Unlevered Free Cash Flow	-21.3M	-13.67M	-12.28M	-12.89M	-15.24M
Change In Net Working Capital	4.98M	-277K	983K	-125K	-468K
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: June	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Profitability
Return on Assets	-32.17	-28.65	-30.66	-35.44	-49.04
Return on Total Capital	-36.43	-32.07	-34.52	-40.64	-61.53
Return On Equity %	-92.62	-121.67	-206.07	-1.02K	277.27
Return on Common Equity	-94.6	-130.53	-310.58	669.52	159.46
Margin Analysis
Gross Profit Margin %	100	96.86	98.77	48.95	44.59
SG&A Margin	7.97K	4.1K	3.08K	746.93	1.01K
EBITDA Margin %	-17.32K	-9.37K	-6.72K	-1.64K	-2.4K
EBITA Margin %	-17.77K	-9.49K	-6.8K	-1.66K	-2.45K
EBIT Margin %	-17.77K	-9.49K	-6.8K	-1.66K	-2.45K
Income From Continuing Operations Margin %	-17.68K	-10.07K	-6.55K	-1.74K	-2.5K
Net Income Margin %	-17.62K	-9.87K	-6.41K	-1.69K	-2.34K
Net Avail. For Common Margin %	-17.62K	-9.87K	-6.41K	-1.69K	-2.34K
Normalized Net Income Margin	-10.99K	-6.09K	-3.95K	-1.04K	-1.41K
Levered Free Cash Flow Margin	-9.34K	-4.95K	-3.93K	-1.01K	-1.56K
Unlevered Free Cash Flow Margin	-9.1K	-4.76K	-3.77K	-965.12	-1.5K
Asset Turnover
Asset Turnover	0	0	0.01	0.03	0.03
Fixed Assets Turnover	0.04	0.03	0.04	0.17	0.12
Receivables Turnover (Average Receivables)	-	-	1.84	4.74	4.99
Short Term Liquidity
Current Ratio	8.46	7.37	6.98	0.68	0.27
Quick Ratio	8.25	7.22	6.88	0.66	0.24
Operating Cash Flow to Current Liabilities	-5.34	-4.07	-4.05	-0.56	-0.6
Days Sales Outstanding (Average Receivables)	-	-	198.72	77.04	73.11
Average Days Payable Outstanding	-	72.94K	127K	489.7	508.28
Long Term Solvency
Total Debt/Equity	89.49	195.46	546.85	-3.94K	-200.26
Total Debt / Total Capital	47.23	66.15	84.54	102.61	199.74
LT Debt/Equity	87.56	191.36	536.53	-705.43	-37.21
Long-Term Debt / Total Capital	46.21	64.77	82.94	18.39	37.11
Total Liabilities / Total Assets	52.71	69.88	86.3	102.24	170.08
EBIT / Interest Expense	-46.89	-32.32	-25.59	-25.4	-26.76
EBITDA / Interest Expense	-44.37	-30.48	-25.29	-25.04	-26.24
(EBITDA - Capex) / Interest Expense	-44.68	-30.79	-25.67	-26.89	-26.92
Total Debt / EBITDA	-0.73	-1.16	-1.35	-1.56	-1.43
Net Debt / EBITDA	0.67	0.4	0.02	-0.61	-1.11
Total Debt / (EBITDA - Capex)	-0.73	-1.15	-1.33	-1.45	-1.39
Net Debt / (EBITDA - Capex)	0.66	0.4	0.02	-0.57	-1.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	22.65	13.59	309.82	-23.95
Gross Profit, 1 Yr. Growth %	-	18.8	15.83	103.11	-30.73
EBITDA, 1 Yr. Growth %	-17.69	-33.69	-18.52	-0.21	11.74
EBITA, 1 Yr. Growth %	-17.84	-34.49	-18.67	0.08	12.45
EBIT, 1 Yr. Growth %	-17.84	-34.49	-18.67	0.08	12.45
Earnings From Cont. Operations, 1 Yr. Growth %	-17.03	-30.18	-26.11	8.93	9.11
Net Income, 1 Yr. Growth %	-17.29	-31.33	-26.25	8.11	5.48
Normalized Net Income, 1 Yr. Growth %	-17.45	-32.02	-26.33	7.63	3.29
Diluted EPS Before Extra, 1 Yr. Growth %	-27.77	-39.69	-35.52	-10.6	-31.4
Accounts Receivable, 1 Yr. Growth %	-	-	121.82	31.15	-72.81
Net Property, Plant and Equip., 1 Yr. Growth %	304.54	-7.64	-12.92	20.38	-11.38
Total Assets, 1 Yr. Growth %	-27.23	-25.37	-22.19	-2.14	-35.69
Tangible Book Value, 1 Yr. Growth %	-47.44	-55.54	-99.28	-13.4K	125.39
Common Equity, 1 Yr. Growth %	-47.44	-55.54	-99.28	-7.23K	236.69
Cash From Operations, 1 Yr. Growth %	18.09	-37.38	-21.16	1.05	7.56
Capital Expenditures, 1 Yr. Growth %	-24.93	-6.43	23.28	400.93	-60.88
Levered Free Cash Flow, 1 Yr. Growth %	74.1	-35.56	-2.85	4.79	17.73
Unlevered Free Cash Flow, 1 Yr. Growth %	70.34	-36.35	-3.08	4.97	18.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	218.97	-	18.03	115.76	76.54
Gross Profit, 2 Yr. CAGR %	218.97	-	17.31	53.38	18.61
EBITDA, 2 Yr. CAGR %	20.53	-26.12	-26.49	-9.83	5.6
EBITA, 2 Yr. CAGR %	18.79	-26.64	-27.01	-9.78	6.09
EBIT, 2 Yr. CAGR %	18.79	-26.64	-27.01	-9.78	6.09
Earnings From Cont. Operations, 2 Yr. CAGR %	19.13	-23.89	-28.18	-10.29	9.02
Net Income, 2 Yr. CAGR %	18.94	-24.64	-28.83	-10.7	6.79
Normalized Net Income, 2 Yr. CAGR %	18.83	-25.09	-29.23	-10.95	5.44
Diluted EPS Before Extra, 2 Yr. CAGR %	-10.57	-34	-37.64	-24.07	-21.69
Accounts Receivable, 2 Yr. CAGR %	-	-	-	70.56	-40.29
Net Property, Plant and Equip., 2 Yr. CAGR %	54.48	93.3	-10.32	2.39	3.29
Total Assets, 2 Yr. CAGR %	1.91	-26.31	-23.79	-12.73	-20.67
Tangible Book Value, 2 Yr. CAGR %	-26.83	-51.66	-94.35	-2.21	1.63K
Common Equity, 2 Yr. CAGR %	-26.83	-51.66	-94.35	-28.42	1.45K
Cash From Operations, 2 Yr. CAGR %	17.65	-14.01	-29.74	-10.74	4.26
Capital Expenditures, 2 Yr. CAGR %	1.84	-16.19	7.4	148.51	39.99
Levered Free Cash Flow, 2 Yr. CAGR %	17.74	6.35	-23.7	0.9	11.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.24	4.56	-24.36	0.86	11.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	63.03	131.94	-	78.73	52.41
Gross Profit, 3 Yr. CAGR %	65.1	129.49	-	40.86	17.68
EBITDA, 3 Yr. CAGR %	6.49	-1.24	-23.67	-18.61	-3.14
EBITA, 3 Yr. CAGR %	5.39	-2.59	-24.07	-18.91	-2.91
EBIT, 3 Yr. CAGR %	5.39	-2.59	-24.07	-18.91	-2.91
Earnings From Cont. Operations, 3 Yr. CAGR %	5.43	-0.3	-24.64	-17.48	-4.24
Net Income, 3 Yr. CAGR %	5.32	-0.96	-25.18	-18.19	-5.6
Normalized Net Income, 3 Yr. CAGR %	5.25	-1.36	-25.51	-18.62	-6.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-23.51	-21.58	-34.51	-29.68	-26.6
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	-7.52
Net Property, Plant and Equip., 3 Yr. CAGR %	32.9	30.14	48.18	-1.07	-2.43
Total Assets, 3 Yr. CAGR %	29.54	-8.14	-24.96	-17.17	-21.18
Tangible Book Value, 3 Yr. CAGR %	11.24	-38.02	-88.11	-24.81	29.17
Common Equity, 3 Yr. CAGR %	11.24	-38.02	-88.11	-38.93	19.93
Cash From Operations, 3 Yr. CAGR %	7.41	-4.65	-16.46	-20.69	-5.01
Capital Expenditures, 3 Yr. CAGR %	5.42	-1	-4.68	79.45	34.18
Levered Free Cash Flow, 3 Yr. CAGR %	10.47	-3.43	0.72	-15.18	6.22
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.53	-4.64	-0.59	-15.63	6.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	41.83	43.27	125.33	-
Gross Profit, 5 Yr. CAGR %	-	42.09	44	95.33	-
EBITDA, 5 Yr. CAGR %	9.42	-3.25	-8.18	-4.77	-13.09
EBITA, 5 Yr. CAGR %	8.22	-4.18	-9.01	-5.53	-13.2
EBIT, 5 Yr. CAGR %	8.22	-4.18	-9.01	-5.53	-13.2
Earnings From Cont. Operations, 5 Yr. CAGR %	8.27	2.03	-9.58	-4.42	-12.64
Net Income, 5 Yr. CAGR %	8.2	1.63	-9.97	-4.98	-13.74
Normalized Net Income, 5 Yr. CAGR %	8.56	-3.68	-10.2	-5.31	-14.4
Diluted EPS Before Extra, 5 Yr. CAGR %	-16.63	-20.72	-29.51	-22.58	-29.65
Accounts Receivable, 5 Yr. CAGR %	-	-	6.39	17.64	-
Net Property, Plant and Equip., 5 Yr. CAGR %	4.36	7.94	13.55	18.24	28.26
Total Assets, 5 Yr. CAGR %	12.64	5.45	4.77	-10.01	-23.27
Tangible Book Value, 5 Yr. CAGR %	-0.14	-14.07	-66.22	-25.62	-12.82
Common Equity, 5 Yr. CAGR %	-0.14	-14.07	-66.22	-34.35	-16.62
Cash From Operations, 5 Yr. CAGR %	11.05	1.34	-9.36	-7.14	-8.72
Capital Expenditures, 5 Yr. CAGR %	-5.83	-5.19	6.21	43.06	11.16
Levered Free Cash Flow, 5 Yr. CAGR %	12.86	9.63	-4.58	-3.14	-9.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.28	8.84	-5.39	-3.94	-10.45